Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Arrowhead Pharmaceuticals, Inc. ARWR

Full chart Compare
Set alert

Price alert · ARWR

All alert types
47.82 USD -10.34 (-17.79%)

Nov 9, 2026, 11:52 AM EST

46.45 Day range 53.63
38.09 52-week range 89.59
YTD
-27.98%
1 year
+21.88%

Financial health

Altman Z-Score

2.58 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2827×
FY 2016: -5.5×FY 2017: -9.2×FY 2018: -29.6×FY 2019: 39.1×FY 2020: -51.3×FY 2021: -45.9×FY 2022: -19.8×FY 2023: -14.0×FY 2024: -3.9×FY 2025: -2827×
FY 2016 5y median -19.8× FY 2025
P/S 5.6×
FY 2016: 2831×FY 2017: 10.1×FY 2018: 99.5×FY 2019: 15.7×FY 2020: 49.3×FY 2021: 46.8×FY 2022: 14.3×FY 2023: 11.9×FY 2024: 653×FY 2025: 5.6×
FY 2016 5y median 14.3× FY 2025
P/B 9.9×
FY 2016: 4.7×FY 2017: 3.9×FY 2018: 16.8×FY 2019: 10.8×FY 2020: 9.4×FY 2021: 15.8×FY 2022: 8.7×FY 2023: 10.6×FY 2024: 12.5×FY 2025: 9.9×
FY 2016 5y median 10.6× FY 2025
P/FCF 29.4×
FY 2016: -6.6×FY 2017: -9.9×FY 2018: -33.0×FY 2019: 16.4×FY 2020: -40.3×FY 2021: 43.8×FY 2022: -18.4×FY 2023: -8.7×FY 2024: -3.8×FY 2025: 29.4×
FY 2016 5y median -3.8× FY 2025
EV/EBITDA 28.8×
FY 2016: -4.8×FY 2017: -9.1×FY 2018: -30.8×FY 2019: 36.9×FY 2020: -48.3×FY 2021: -47.7×FY 2022: -21.3×FY 2023: -17.9×FY 2024: -5.5×FY 2025: 28.8×
FY 2016 5y median -17.9× FY 2025
EV/Sales 5.7×
FY 2016: 2309×FY 2017: 9.4×FY 2018: 97.8×FY 2019: 14.4×FY 2020: 47.9×FY 2021: 45.7×FY 2022: 14.2×FY 2023: 13.0×FY 2024: 864×FY 2025: 5.7×
FY 2016 5y median 14.2× FY 2025
FCF Yield 3.4%
FY 2016: -15.2%FY 2017: -10.1%FY 2018: -3.0%FY 2019: 6.1%FY 2020: -2.5%FY 2021: 2.3%FY 2022: -5.4%FY 2023: -11.5%FY 2024: -26.0%FY 2025: 3.4%
FY 2016 5y median -5.4% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 95.7%FY 2023: 94.8%FY 2024: -423.7%FY 2025: 100.0%
FY 2016 5y median 95.7% FY 2025
Operating Margin 11.9%
FY 2016: -51627.1%FY 2017: -117.8%FY 2018: -346.5%FY 2019: 36.3%FY 2020: -105.9%FY 2021: -107.8%FY 2022: -73.4%FY 2023: -85.2%FY 2024: -16927.1%FY 2025: 11.9%
FY 2016 5y median -85.2% FY 2025
Net Margin -0.2%
FY 2016: -51614.6%FY 2017: -109.5%FY 2018: -337.3%FY 2019: 40.3%FY 2020: -96.1%FY 2021: -101.9%FY 2022: -72.4%FY 2023: -85.3%FY 2024: -16882.4%FY 2025: -0.2%
FY 2016 5y median -85.3% FY 2025
ROE -0.3%
FY 2016: -85.5%FY 2017: -42.2%FY 2018: -56.8%FY 2019: 27.8%FY 2020: -18.3%FY 2021: -34.5%FY 2022: -44.2%FY 2023: -75.7%FY 2024: -323.3%FY 2025: -0.3%
FY 2016 5y median -44.2% FY 2025
ROIC 4.6%
FY 2016: -79.6%FY 2017: -43.3%FY 2018: -56.2%FY 2019: 24.1%FY 2020: -19.3%FY 2021: -26.3%FY 2022: -32.1%FY 2023: -30.6%FY 2024: -57.4%FY 2025: 4.6%
FY 2016 5y median -30.6% FY 2025
ROA -0.1%
FY 2016: -63.8%FY 2017: -33.1%FY 2018: -48.8%FY 2019: 19.4%FY 2020: -16.2%FY 2021: -19.8%FY 2022: -25.4%FY 2023: -26.8%FY 2024: -52.6%FY 2025: -0.1%
FY 2016 5y median -25.4% FY 2025

Growth (YoY)

Revenue 23258.2%
FY 2016: -58.6%FY 2017: 19736.5%FY 2018: -48.6%FY 2019: 945.7%FY 2020: -47.9%FY 2021: 57.2%FY 2022: 75.9%FY 2023: -1.0%FY 2024: -98.5%FY 2025: 23258.2%
FY 2016 FY 2025
Operating Income 116.4%
FY 2016: 14.8%FY 2017: 54.7%FY 2018: -51.2%FY 2019: 209.4%FY 2020: -252.2%FY 2021: -60.0%FY 2022: -19.8%FY 2023: -14.8%FY 2024: -193.2%FY 2025: 116.4%
FY 2016 FY 2025
EPS (diluted) 99.8%
FY 2016: 16.3%FY 2017: 64.9%FY 2018: -38.3%FY 2019: 206.2%FY 2020: -221.7%FY 2021: -61.9%FY 2022: -22.8%FY 2023: -15.0%FY 2024: -160.4%FY 2025: 99.8%
FY 2016 FY 2025
Free Cash Flow 126.0%
FY 2016: -0.9%FY 2017: 53.3%FY 2018: -52.7%FY 2019: 431.0%FY 2020: -166.9%FY 2021: 237.1%FY 2022: -227.9%FY 2023: -75.0%FY 2024: -82.8%FY 2025: 126.0%
FY 2016 FY 2025

Financial Health

Current Ratio 4.9×
FY 2016: 3.5×FY 2017: 3.6×FY 2018: 6.4×FY 2019: 2.7×FY 2020: 7.9×FY 2021: 2.6×FY 2022: 2.9×FY 2023: 4.0×FY 2024: 6.7×FY 2025: 4.9×
FY 2016 5y median 4.0× FY 2025
Quick Ratio 4.9×
FY 2016: 3.5×FY 2017: 3.6×FY 2018: 6.3×FY 2019: 2.7×FY 2020: 7.8×FY 2021: 2.6×FY 2022: 3.1×FY 2023: 4.0×FY 2024: 6.7×FY 2025: 4.9×
FY 2016 5y median 4.0× FY 2025
Debt / Equity 0.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 1.4×FY 2024: 4.6×FY 2025: 0.8×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 0.8×
FY 2016: 1.1×FY 2017: 0.7×FY 2018: 0.5×FY 2019: -3.4×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 0.2×FY 2023: -1.6×FY 2024: -1.3×FY 2025: 0.8×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 1.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -11.2×FY 2024: -18.6×FY 2025: 1.1×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30